Related Experiment Video
Updated: Jul 15, 2026
07:03
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Antiresorptive agents and osteoclast apoptosis
1Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA. p-stern@northwestern.edu
Journal of Cellular Biochemistry
|April 5, 2007
Summary
Antiresorptive agents combat bone diseases by reducing osteoclast survival via apoptosis. This review explores how these agents induce programmed cell death and their impact on bone resorption.
Area of Science:
- Bone biology and pharmacology
- Cellular mechanisms of bone resorption
- Therapeutic strategies for bone diseases
Background:
- Osteoclast activity drives bone diseases.
- Antiresorptive agents target osteoclasts through various mechanisms.
- Osteoclast survival is crucial and influenced by cellular factors.
Purpose of the Study:
- To present evidence that antiresorptive agents induce osteoclast apoptosis.
- To review the mechanisms of apoptosis induction by these agents.
- To evaluate the role of apoptosis in the overall antiresorptive effect.
Main Methods:
- Literature review of antiresorptive agents and apoptosis.
- Analysis of mechanisms linking antiresorption and apoptosis.
- Discussion of therapeutic agents with dual actions.
Main Results:
- Antiresorptive agents demonstrate efficacy in reducing osteoclast survival through apoptosis.
- Specific mechanisms of apoptosis activation by therapeutic agents are identified.
- The extent to which apoptosis accounts for antiresorptive effects is considered.
Conclusions:
- Antiresorptive agents can effectively induce osteoclast apoptosis, contributing to their therapeutic benefits.
- Understanding these mechanisms may lead to novel therapeutic approaches for bone diseases.
- Further research is warranted to fully elucidate the role of apoptosis in antiresorptive therapy.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.